(Press-News.org) Independent reproduction of other scientists' results is a cornerstone of solid research, but scientists are rarely recognized for successfully reproducing published findings, much less for demonstrating that scientific findings cannot be reproduced. However, failure to reproduce a finding may suggest doubt about the robustness of the original work, which carries implications for anyone looking to build on those findings.
University of Iowa neuroscientist Andrew Pieper unexpectedly found himself in the position of contradicting seemingly promising results published in 2012 in the journal Nature that prompted a clinical trial for human patients.
The original study from the laboratory of Jonathan Kipnis at the University of Virginia School of Medicine, conducted in mice, suggested that a bone marrow transplant from a healthy mouse could prevent the development of Rett syndrome--a severe neurodevelopmental disorder on the autism spectrum--and prolong the lifespan of the treated mice. The study also suggested that the bone marrow transplant arrested the disease because it restored normal microglia cells to the affected animals' brains.
The finding was exciting because it suggested that an approach already used in medicine might provide a treatment for a devastating and incurable disease that strikes very young children. On the basis of this work, a clinical trial for bone marrow transplantation in patients with Rett syndrome was initiated at the University of Minnesota.
Rett syndrome is caused by mutations in the X-linked MECP2 gene and affects about 1 in every 10,000 girls (it is most often fatal in boys at or near birth). Rett syndrome causes many disabilities, both intellectual and physical. Because many different MECP2 mutations can cause Rett syndrome, a wide range of disability, from mild to severe, can result from the disorder.
Pieper was asked by the Rett Syndrome Research Trust to confirm the results from the Kipnis laboratory. Pieper's group used the same mice and bone marrow transplantation methods as the original study, as well as the same outcome measures, but conducted a more highly-powered experiment on a larger number of animals. Pieper also randomized the treatment and used blinded methods to analyze the results. His team found no benefit to the bone marrow transplant.
Moreover, three other groups--the laboratory of Jeffrey Neul at Baylor College of Medicine in Houston, Texas; the laboratory of Antonio Bedalov at Fred Hutchinson Cancer Research Center in Seattle, Wash.; and the laboratory of Peter Huppke at the University Medical Center Gottingen, in Germany--also were unable to reproduce the original findings.
The four independent research groups decided to pool their findings into a single manuscript, which they submitted to Nature, the same journal where the original study was published. The new studies found that bone marrow transplant provided no benefit in terms of alleviating symptoms or extending lifespan in three separate mouse models of Rett syndrome. In addition, they showed that even early, targeted rescue of MECP2 expression specifically in microglia cells did not rescue the animals from disease.
"In group discussions about the data with Dr. Kipnis, we were unable to determine why bone marrow transplantation worked so well in his laboratory and not our laboratories," says Pieper, associate professor of psychiatry in the UI Carver College of Medicine.
The new work was published as a "Brief Communication Arising" in the journal Nature on May 20. According to the journal, this new form of peer-reviewed article provides a mechanism to publish exceptionally interesting or important scientific comments and clarifications on original research papers or other peer-reviewed material published in Nature. Specifically, Brief Communications Arising are manuscripts that challenge the main conclusions of a previously published Nature paper and contain new, unpublished data to support the arguments. A unique aspect of this format is that Brief Communications Arising are linked bidirectionally with the original published paper, facilitating dissemination of the full body of work to all readers.
Success rates for turning promising preclinical results into human therapies is generally low. Increasing the rigor and reliability of preclinical trials should help improve that success rate.
"It's important for families of children with Rett syndrome, as well as clinicians and researchers, to be aware of the full body of work that has been conducted in this area," Pieper says. "This new publication format by Nature perfectly facilitates this goal."
INFORMATION:
BUFFALO, N.Y. - A false tweet from a hacked account owned by the Associated Press (AP) in 2013 sent financial markets into a tailspin. The Dow Jones Industrial Average dropped 143.5 points and the Standard & Poor's 500 Index lost more than $136 billion of its value in the seconds that immediately followed the post.
Once the nature of the tweet was discovered, the markets corrected themselves almost as quickly as they were skewed by the bogus information, but the event, known as Hack Crash, demonstrates the need to better understand how social media data is linked to decision ...
Washington, DC--An unborn child's gender can affect the mother's risk of developing gestational diabetes or Type 2 diabetes later in life, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Gestational diabetes occurs when a pregnant woman has higher levels of glucose, or blood sugar, in the bloodstream than normal. Women who have been diagnosed with gestational diabetes face a greater risk of developing Type 2 diabetes in the future. As many as 9 percent of pregnant women develop gestational diabetes, according ...
Washington, DC--People who have metabolic syndrome are more likely to die from cardiovascular disease than people who do not have the condition, and having diabetes or high blood pressure worsens the risk, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Metabolic syndrome is a cluster of risk factors that raise the chances of developing heart disease, stroke and diabetes, according to the Hormone Health Network. The risk factors include abdominal obesity, high levels of fats in the blood called triglycerides, ...
Scientists have captured the early death throes of supernovae for the first time and found that the universe's benchmark explosions are much more varied than expected.
The scientists used the Kepler space telescope to photograph three type 1a supernovae in the earliest stages of ignition. They then tracked the explosions in detail to full brightness around three weeks later, and the subsequent decline over the next few months.
They found the initial stages of a supernova explosion did not fit with the existing theories.
"The stars all blow up uniquely. It doesn't ...
DURHAM, N.C. -- Gamers might one day be able to enjoy the same graphics-intensive fast-action video games they play on their gaming consoles or personal computers from mobile devices without guzzling gigabytes, thanks to a new tool developed by researchers at Duke University and Microsoft Research.
Named "Kahawai" after the Hawaiian word for stream, the tool delivers graphics and gameplay on par with conventional cloud-gaming setups for a fraction of the bandwidth.
"That's a huge win, especially if your cellphone plan has a data cap," said Duke computer scientist Landon ...
Scientists at the University of Alberta's Institute for Stuttering Treatment and Research (ISTAR) want Albertans to give a spit -- five millilitres to be precise -- to help find the cause and a cure for stuttering.Scientists at the University of Alberta's Institute for Stuttering Treatment and Research (ISTAR) want Albertans to give a spit -- five millilitres to be precise -- to help find the cause and a cure for stuttering.
ISTAR researchers have collected saliva samples from 150 people who stutter and their family members, part of a first-of-its-kind DNA repository ...
Women who choose not to participate in a clinical trial may be significantly more likely to later regret that decision than women who choose to participate in the study, according to a team of Penn State researchers.
The finding may help hospitals and health researchers attract more recruits for clinical trials, a task which many physicians consider the biggest obstacle to conducting these trials, according to the researchers. Typically, as many as 20 percent of a given population of patients are eligible to participate in clinical research. However, of those, only 2 ...
In a state known for its dramatic weather and climate, Colorado's history of extreme precipitation varies considerably by season and location, according to a new study led by the Cooperative Institute for Research in Environmental Science, a partnership between the University of Colorado Boulder and NOAA.
Decision makers -- often facing increased pressure to consider climate change information -- typically turn to historical averages to understand when and where extreme rain, hail and snow happen in the state. But those averages often are not reliable because they're ...
INDIANAPOLIS -- Researchers with the Indiana University School of Medicine have identified a molecule that promotes metastasis of advanced prostate cancer to the bone, an incurable condition that significantly decreases quality of life. The research, published online in the journal Cancer Cell, may offer new targets for diagnosing and treating this common disease.
The researchers homed in on a protein that is essential in multiple cell functions such as cell growth and proliferation and, in some cases, natural cell death. The protein, TGF-beta, also has been found to ...
ATS 2015, DENVER -- Treatment of COPD with inhaled corticosteroids (ICS) may decrease the risk of dying from pneumonia and from other causes despite being associated with an increase in the occurrence of pneumonia, according to a new meta-analysis presented at the 2015 American Thoracic Society International Conference.
"Our systematic review and meta-analysis of 38 studies echoes individual studies which have shown that while ICS use may increase the risk of pneumonia in COPD patients, it lowers the risk of both pneumonia-associated and overall mortality," said lead ...
